Concepedia

Edgar B. Francisco

EB

Statistics

Publications

9

Citations

836

H-Index

9

Active since

2020

Affiliations

Incell Corporation (United States)(Current)

Universidad de Costa Rica

Oregon Health & Science University

Bio-Rad (United States)

Lawrence General Hospital

Edgar B. Francisco is an author at Incell Corporation (United States) specializing in immunology, covid-19, and medicine.

Top concepts

Publications per year

2020–2025

9

Publications

9

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Bruce K. Patterson, Edgar B. Francisco, Ram Yogendra et al. · Frontiers in Immunology · 2022 · 277 citations · Full text

, , +17

Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning

Bruce K. Patterson, José Guevara-Coto, Ram Yogendra et al. · Frontiers in Immunology · 2021 · 201 citations · Full text

CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

Bruce K. Patterson, Harish Seethamraju, Kush Dhody et al. · International Journal of Infectious Diseases · 2020 · 146 citations · Full text

Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19

Bruce K. Patterson, Harish Seethamraju, Kush Dhody et al. · 2020 · 103 citations · Full text

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) Up to 15 Months Post-Infection

Bruce K. Patterson, Edgar B. Francisco, Ram Yogendra et al. · 2021 · 39 citations · Full text

, , +21

1–5 of 9